Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve
- PMID: 3746633
- DOI: 10.1007/BF01059285
Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve
Abstract
A mathematical model for area under the curve (AUC) determination is proposed taking into account the circadian variation of cisplatin protein binding. The main theoretical result obtained with the model is that early morning drug administration (2-4 AM) promotes the highest AUC. The model predicts a maximum AUC variation, due to the binding variation, ranging between 2.4 and 15%. The minimum of AUC between 2.45 and 3.30 PM is in agreement with the minimum nephrotoxicity observed when cisplatin is injected in the afternoon. The model can be applied to other drugs that are irreversively bound to proteins or irreversively bound to other plasma components if the binding rate depends on the time of day. The variation intensity of AUC was demonstrated to depend on drug characteristics, but can never be higher than the circadian variation of the protein binding rate.
Similar articles
-
Time dependency in plasmatic protein binding of cisplatin.Cancer Treat Rep. 1985 Jan;69(1):79-83. Cancer Treat Rep. 1985. PMID: 4038472
-
The in vitro binding kinetics of cisplatin to human plasma proteins is not affected by glutathione.Boll Chim Farm. 1997 Apr;136(4):301-3. Boll Chim Farm. 1997. PMID: 9281890 Clinical Trial. No abstract available.
-
Stability of a cisplatin-chondroitin sulfate A complex in plasma and kidney in terms of protein binding.Biol Pharm Bull. 2001 Aug;24(8):970-2. doi: 10.1248/bpb.24.970. Biol Pharm Bull. 2001. PMID: 11510498
-
The influence of circadian rhythms on the kinetics of drugs in humans.Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):175-92. doi: 10.1517/17425255.4.2.175. Expert Opin Drug Metab Toxicol. 2008. PMID: 18248311 Review.
-
Clinical pharmacokinetics of carboplatin.Clin Pharmacokinet. 1991 Oct;21(4):242-61. doi: 10.2165/00003088-199121040-00002. Clin Pharmacokinet. 1991. PMID: 1760899 Review.
Cited by
-
Chronopharmacokinetics. Current status.Clin Pharmacokinet. 1998 Aug;35(2):83-94. doi: 10.2165/00003088-199835020-00001. Clin Pharmacokinet. 1998. PMID: 9739478 Review.
-
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.Cancer Cell Int. 2015 Jul 15;15:71. doi: 10.1186/s12935-015-0221-1. eCollection 2015. Cancer Cell Int. 2015. PMID: 26180516 Free PMC article.